Connection

WILLIAM WONG to Carbazoles

This is a "connection" page, showing publications WILLIAM WONG has written about Carbazoles.
Connection Strength

0.231
  1. Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada. Curr Oncol. 2024 Dec 27; 32(1).
    View in: PubMed
    Score: 0.231
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.